Departments and specialties

Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery.

Departments with related expertise

Areas that research this procedure

Research

Diagnostic radiologists

Doctors who specialize in diagnostic radiology research new ways of using advanced, high-resolution imaging, such as PET MRI, to care for people undergoing Whipple procedures.

Mayo Clinic surgeons developed a new protocol that makes Whipple surgery an option for more people and improves the survival among this group.

Because more people are living longer after Whipple procedure than they did in the past, Mayo Clinic researchers are examining how to improve quality of life after surgery.

In addition, Mayo Clinic is one of the few medical centers in the U.S. recognized as a Specialized Program of Research Excellence (SPORE) for pancreatic cancer research, funded by the National Cancer Institute. And in the Mayo Clinic Gastrointestinal Cancer Program, new diagnostic tools, treatments and approaches to prevention of pancreatic cancer are being studied. Mayo Clinic doctors in this program are dedicated to advancing scientific knowledge of cancers affecting the intestinal tract and to improving the quality of life of people affected by these diseases.

Publications

See a list of publications by Mayo Clinic doctors on pancreatic cancer on PubMed, a service of the National Library of Medicine.

Research Profiles

Whipple procedure care at Mayo Clinic

May 24, 2017
References
  1. Delaney CP. Pancreaticoduodenectomy. In: Netter's Surgical Anatomy and Approaches. Philadelphia, Pa.: Saunders Elsevier; 2014. https://www.clinicalkey.com. Accessed Feb. 22, 2017.
  2. Townsend CM Jr, et al. Exocrine pancreas. In: Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 20th ed. Philadelphia, Pa.: Elsevier; 2017. https://www.clinicalkey.com. Accessed Feb. 22, 2017.
  3. Reber HA. Surgical resection of lesions of the head of the pancreas. http://www.uptodate.com/home. Accessed Feb. 22, 2017.
  4. Croome KP, et al. Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Oncologic advantages over open approaches? Annals of Surgery. 2014;260:633.
  5. Asbun HJ, et al. Laparoscopic vs open pancreaticoduodenectomy: Overall outcomes and severity of complications using the Accordion Severity Grading System. Journal of the American College of Surgeons. 2012;215:810.
  6. Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. Feb. 9, 2017.
  7. Truty MJ (expert opinion). Mayo Clinic, Rochester, Minn. Feb. 22, 2017.
  8. Niederhuber JE, et al., eds. Carcinoma of the pancreas. In: Abeloff's Clinical Oncology. 5th ed. Philadelphia, Pa.: Churchill Livingstone Elsevier; 2014. http://www.clinicalkey.com. Accessed June 3, 2016.
  9. AskMayoExpert. Pancreatic cancer. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
  10. Pancreatic SPOREs. National Cancer Institute. http://trp.cancer.gov/spores/pancreatic.htm. Accessed. June 10, 2016.
  11. Thiels CA, et al. Outcomes of pancreaticoduodenectomy for pancreatic neuroendocrine tumors: Are combined procedures justified? Journal of Gastrointestinal Surgery. 2016;20:891.
  12. Ivanics T, et al. Small cell carcinoma of the pancreas: A surgical disease. Pancreas. 2016;45:1461.
  13. Barbara Woodward Lips Patient Education Center. Surgery of the extrahepatic bile duct, duodenum, papilla, or pancreas. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2012.
  14. Bergquist JR, et al. Implications of CA19-9 elevation for survival, staging and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis. Journal of Surgical Oncology. 2016;114:475.
  15. Katz MH, et al. Preoperative modified FOLFIRINOX treatment followed by Capecitabine-based chemoradiation for borderline resectable pancreatic cancer: Alliance for Clinical Trials in Oncology Trial A021101. JAMA Surgery. 2016;151:e161137. Accessed March 29, 2017.
  16. Shubert CR, et al. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database. Surgery. 2016;160:1080.
  17. Bergquist JR, et al. Risk by indication for pancreaticoduodenectomy in patients 80 years and older: A study from the American College of Surgeons National Surgical Quality Improvement Program. HPB. 2016;18:900.